MedTrace Logo

Effects of Menthol on Dyspnoea in COPD Patients

NCT03626519 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2021-04-23

No results posted yet for this study

Summary

Chronic obstructive pulmonary disease (COPD) is characterised by non-reversible bronchial obstruction associated with systemic disorders and comorbid factors. Dyspnoea is a common symptom among patients with Chronic Obstructive pulmonary Disease (COPD). Dyspnea is the primary symptom limiting exercise and daily activities in these patients. It has been reported that breathing cold air could decrease dyspnoea induced by exercise and could improve exercise performance. The aim of this study is to carry out the effect of cooling sensation induced by menthol chewing-gum on dyspnoea and exercise performance among patients with COPD.

Conditions

Interventions

OTHER

Test with Menthol

patients will perform a Six-minute walk test according to American Thoracic Society guidelines

OTHER

Test with placebo

patients will perform a Six-minute walk test according to American Thoracic Society guidelines

Sponsors & Collaborators

  • Groupe Hospitalier du Havre

    lead OTHER

Principal Investigators

  • Guillaume Prieur · Groupe Hospitalier du Havre

  • Marc Beaumont · Centre Hospitalier des Pays de Morlaix

  • Mathieu Delorme · Resp'Air, Talence

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-23
Primary Completion
2021-03-12
Completion
2021-03-12

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03626519 on ClinicalTrials.gov